Muscle-based gene therapy and tissue engineering to improve bone healing

Clinical Orthopaedics and Related Research

Volumn 403, Issue SUPPL., 2002, Pages

  Young, Brett H ^a   Peng, Hairong ^a   Huard, Johnny ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2;

BONE REGENERATION; CALVARIA; CELL SURVIVAL; CONFERENCE PAPER; FRACTURE HEALING; FRACTURE NONUNION; GENE DELIVERY SYSTEM; GENE THERAPY; MORBIDITY; MUSCLE REGENERATION; OSTEOBLAST; OSTEOCYTE; OSTEOPOROSIS; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCAPHOID FRACTURE; STEM CELL; TISSUE ENGINEERING;

EID: 0036808899     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1097/00003086-200210001-00028     Document Type: Conference Paper

References (52)

1. Andres V, Walsh K: Myogenin expression, cell cycle withdrawal, and phenotypic differentiation are temporally separable events that precede cell fusion upon myogenesis. J Cell Biol 132:657-666, 1996.
2. Ashammakhi N, Arnaud E, Marchac D, et al: Musculoskeletal tissue engineering with resorbable polymers. Ann Chir Plast Esthet 45:610-616, 2000.
3. Beauchamp JR, Heslop L, Yu DS, et al: Expression of CD34 and Myf5 defines the majority of quiescent adult skeletal muscle satellite cells. J Cell Biol 151:1221-1234, 2000.
4. Blau HM, Springer ML: Muscle-mediated gene therapy. N Engl J Med 333:1554-1556, 1995.
5. Bosch P, Musgrave D, Ghivizzani S, et al: The efficiency of muscle-derived cell-mediated bone formation. Cell Transplant 9:463-470, 2000.
6. Bosch P, Musgrave DS, Lee JY, et al: Osteoprogenitor cells within skeletal muscle. J Orthop Res 18:933-944, 2000.
7. Bostrom M, Lane JM, Tomin E, et al: Use of bone morphogenetic protein-2 in the rabbit ulnar nonunion model. Clin Orthop 327:272-282, 1996.
8. Bostrom MP, Lane JM, Berberian WS, et al: Immunolocalization and expression of bone morphogenetic proteins 2 and 4 in fracture healing. J Orthop Res 13:357-367, 1995.
9. Bruder SP, Fink DJ, Caplan AI: Mesenchymal stem cells in bone development, bone repair, and skeletal regeneration therapy. J Cell Biochem 56:283-294, 1994.
10. Bruder SP, Fox BS: Tissue engineering of bone: Cell based strategies. Clin Orthop 367 (Suppl):S68-S83, 1999.
11. Connolly J, Guse R, Lippiello L, Dehne R: Development of an osteogenic bone-marrow preparation. J Bone Joint Surg 71A:684-691, 1989.
12. Constam DB, Robertson EJ: Regulation of bone morphogenetic protein activity by pro domains and proprotein convertases. J Cell Biol 144:139-149, 1999.
13. Cook SD, Baffes GC, Wolfe MW, et al: The effect of recombinant human osteogenic protein-1 on healing of large segmental bone defects. J Bone Joint Surg 76A:827-838, 1994.
14. Cornelison DD, Wold BJ: Single-cell analysis of regulatory gene expression in quiescent and activated mouse skeletal muscle satellite cells. Dev Biol 191:270-283, 1997.
15. Damien CJ, Parsons JR: Bone graft and bone graft substitutes: Review of current technology and applications. J Appl Biomater 2:187-208, 1991.
16. Day CS, Bosch P, Kasemkijwaltana C, et al: Use of muscle cells to mediate gene transfer to the bone defect. Tissue Eng 5:119-125, 1999.
17. Duppe H, Johnell O, Lundborg G, Karlsson M, Redlund-Johnell I: Long-term results of fracture of the scaphoid: A follow-up study of more than thirty years. J Bone Joint Surg 76A:249-252, 1994.
18. Einhorn TA: Enhancement of fracture-healing, J Bone Joint Surg 77A:940-956, 1995.
19. Evans CH, Robbins PD, Ghivizzani SC, et al: Clinical trial to assess the safety, feasibility, and efficacy of transferring a potentially anti-arthritic cytokine gene to human joints with rheumatoid arthritis. Hum Gene Ther 7:1261-1280, 1996.
20. Fowler BL, Dall BE, Rowe DE: Complications associated with harvesting autogenous iliac bone graft. Am J Orthop 24:895-903, 1995.
21. Frost HM: From Wolff's law to the Utah paradigm: Insights about bone physiology and its clinical applications. Anat Rec 262:398-419, 2001.
22. Gannon FH, Glaser D, Caron R, et al: Mast cell involvement in fibrodysplasia ossificans progressiva. Hum Pathol 32:842-848, 2001.
23. Garg NK, Gaur S, Sharma S: Percutaneous autogenous bone marrow grafting in 20 cases of ununited fracture. Acta Orthop Scand 64:671-672, 1993.
24. Goulet JA, Senunas LE, DeSilva GL, Greenfield ML: Autogenous iliac crest bone graft: Complications and functional assessment. Clin Orthop 339:76-81, 1997.
25. Griffith DL, Keck PC, Sampath TK, Rueger DC, Carlson WD: Three-dimensional structure of recombinant human osteogenic protein 1: Structural paradigm for the transforming growth factor beta superfamily. Proc Natl Acad Sci USA 93:878-883, 1996.
26. Halevy O, Novitch BG, Spicer DB, et al: Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 267:1018-1021, 1995.
27. Kang R, Ghivizzani SC, Herndon JH, Robbins PD, Evans CH: Gene therapy for arthritis: Principles and clinical practice. Biochem Soc Trans 25:533-537, 1997.
28. Katagiri T, Yamaguchi A, Komaki M, et al: Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J Cell Biol 127:1755-1766, 1994.
29. Khouri RK, Brown DM, Koudsi B, et al: Repair of calvarial defects with flap tissue: Role of bone morphogenetic proteins and competent responding tissues. Plast Reconstr Surg 98:103-109, 1996.
30. Krebsbach PH, Mankani MH, Satomura K, Kuznetsov SA, Robey PG: Repair of craniotomy defects using bone marrow stromal cells. Transplantation 66:1272-1278, 1998.
31. Lee JY, Musgrave D, Pelinkovic D, et al: Effect of bone morphogenetic protein-2-expressing muscle-derived cells on healing of critical-sized bone defects in mice. J Bone Joint Surg 83A:1032-1039, 2001.
32. Lee JY, Qu-Peterson Z, Cao B, et al: Clonal isolation of muscle-derived cells capable of enhancing muscle regeneration and bone healing. J Cell Biol 150:1085-1100, 2000.
33. Musgrave DS, Bosch P, Ghivizzani S, et al: Adenovirus-mediated direct gene therapy with bone morphogenetic protein-2 produces bone. Bone 24:541-547, 1999.
34. Musgrave DS, Bosch P, Lee JY, et al: Ex vivo gene therapy to produce bone using different cell types. Clin Orthop 378:290-305, 2000.
35. Musgrave DS, Pruchnic R, Wright V, et al: The effect of bone morphogenetic protein-2 expression on the early fate of skeletal muscle-derived cells. Bone 28:499-506, 2001.
36. Pelinkovic D, Lee JY, Adachi N, Fu FH, Huard J: Muscle-based gene therapy and tissue engineering. Crit Rev Eukaryot Gene Expr 11:121-129, 2001.
37. Petersen ZQ, Huard J: The influence of muscle fiber type in myoblast-mediated gene transfer to skeletal muscles. Cell Transplant 9:503-517, 2000.
38. Praemer A, Furner S, Rice D: Musculoskeletal injuries. In Praemer A, Furner S, Rice D (eds). Musculoskeletal Conditions in the United States. Park Ridge, IL, American Academy of Orthopaedic Surgeons 85-124, 1992.
39. Qu Z, Balkir L, van Deutekom JC, et al: Development of approaches to improve cell survival in myoblast transfer therapy. J Cell Biol 142:1257-1267, 1998.
40. Qu Z, Huard J: Matching host muscle and donor myosin heavy chain improves myoblast transfer therapy. Gene Ther 7:428-437, 2000.
41. Rando TA, Blau HM: Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy. J Cell Biol 125:1275-1287, 1994.
42. Reddi AH: Bone morphogenetic proteins: From basic science to clinical applications. J Bone Joint Surg 83A (Suppl):S1-S6, 2001.
43. Richler C, Yaffe D: The in vitro cultivation and differentiation capacities of myogenic cell lines. Dev Biol 23:1-22, 1970.
44. Seale P, Rudnicki MA: A new look at the origin, function, and "stem-cell" status of muscle satellite cells. Dev Biol 218:115-124, 2000.
45. Shafritz AB, Shore EM, Gannon FH, et al: Overexpression of an osteogenic morphogen in fibrodysplasia ossificans progressiva. N Engl J Med 335:555-561, 1996.
46. Sharma S, Garg NK, Veliath AJ, Subramanian S, Srivastava KK: Percutaneous bone-marrow grafting of osteotomies and bony defects in rabbits. Acta Orthop Scand 63:166-169, 1992.
47. Svensson EC, Tripathy SK, Leiden JM: Muscle-based gene therapy: Realistic possibilities for the future. Mol Med Today 2:166-172, 1996.
48. Urist MR: Bone: Formation by autoinduction. Science 150:893-899, 1965.
49. van Deutekom JC, Hoffman EP, Huard J: Muscle maturation: Implications for gene therapy. Mol Med Today 4:214-220, 1998.
50. Wright VJ, Peng H, Huard J: Muscle-based gene therapy and tissue engineering for the musculoskeletal system. Drug Discov Today 6:728-733, 2001.
51. Yamaguchi A, Katagiri T, Ikeda T, et al: Recombinant human bone morphogenetic protein-2 stimulates osteoblastic maturation and inhibits myogenic differentiation in vitro. J Cell Biol 113:681-687, 1991.
52. Yoshida N, Yoshida S, Koishi K, Masuda K, Nabeshima Y: Cell heterogeneity upon myogenic differentiation: Down-regulation of MyoD and Myf-5 generates reserve cells. J Cell Sci 111:769-779, 1998.